Main Article Content
Introduction: Cholera is a destructive disease that causes extreme and intense water loss in the body. It takes between 12 hours and 5 days for an individual to show symptoms after ingesting contaminated food or water. It causes acute watery diarrhea in children and adults and if left untreated, it can lead to death within hours. Unfortunately, children are the most severely affected. In this study, molecular interactions of 24 bioactive compounds of Psidium guajava leaves against Vibrio cholerae targets proteins namely: Alanine racemase (PDB ID: 4BEQ), Cholera enterotoxin, A chain (PDB ID: 1S5F) and ToxT (PDB ID: 3GBG) were evaluated.
Methods: Molecular docking study was conducted and the 3D structures of bioactive compounds, Enzymes and the Enzyme-ligand interaction were visualized while Swiss ADME was employed to assess other physiochemical properties of these bioactive compounds.
Results and Discussion: The results from the molecular docking revealed that five bioactive compounds showed promising inhibitory activity, which include Spathulenol (Binding energy; -7.5, -6.5 and -9.1 kcal/mol in 4BEQ, 1S5F and 3GBG ), Humulene oxide II (Binding energy; -7.1, -6.0 and -8.5 kcal/mol in 4BEQ, 1S5F and 3GBG), Globulol(-)-Globulol were -7.2, -6.5 and -9.0 kcal/mol in 4BEQ, 1S5F and 3GBG), Cadala-1(10),3,8-triene (Binding energy; -7.8, -6.8 and -9.8 kcal/mol in 4BEQ, 1S5F and 3GBG) and Bicyclo[5.3.0]decane, 2-methylene-5-(1-methylvinyl)-8-methyl (Binding energy; -6.9, -6.7 and -9.4 kcal/mol in 4BEQ, 1S5F and 3GBG) respectively.
Conclusion: In this study, it has been revealed that the carefully chosen bioactive compounds have the potential to be used alone or in combination with other natural products for developing potent antibacterial drugs (against cholera). They can be further subjected to fractionation and isolation to confirm their activity towards in vitro and in vivo studies and can be commercialized as a potent antibacterial agent.
World Health Organization / Emerging and other Communicable Disease, Surveillance and Control. WHO guidance on formation of national policy on the control of cholera. WHO/CDD/SER/92.16. [Accessed 2018 Jun 14] Available:https://www.who.int/topics/cholera/publications/WHO_CDD_SER_92_16/en
Ali M, Nelson AR, Lopez AL, Sack DA. Updated global burden of cholera in endemic countries. PLoS neglected tropical diseases. 2015:9(6).
Centers for Disease Control and Prevention. Cholera – Vibrio cholerae infection; 2014. [Accessed 2018 Jun 14] Available:https://www.cdc.gov/cholera/index.html
Halpern M, Izhaki I. Fish as Hosts of Vibrio cholerae. Frontiers in Microbiology. 2017;8:282. DOI: 10.3389/fmicb.2017.00282
Matthey N, Blokesch M. The DNA-Uptake Process of Naturally Competent Vibrio cholerae. Trends Microbiol. 2016;24(2): 98-110. DOI: 10.1016/j.tim.2015.10.008
Sack DA, Sack RB, Nair GB, Siddique AK. Cholera. Lancet. 2004;363(9404):223-33. DOI: 10.1016/S0140-6736(03)15328-7.
World Health organization. Cholera - key facts. 2018 [accessed 2018 Jun 14]. Available:http://www.who.int/en/newsroom/fact-sheets/detail/cholera.
Clemens JD, Nair GB, Ahmed T, Qadri F, Holmgren J. Cholera. The Lancet. 2017;390(10101):1539–1549. DOI: 10.1016/s0140-6736(17)30559-7
Verma AK, Maurya SK, Kumar A, Barik M, Yadav V, Umar B, et al. Inhibition of multidrug resistance property of Candida albicans by natural compounds of parthenium hysterophorus L . An In- Silico approach. Journal of Pharmacognosy and Phytochemistry. 2020:9(3);55–64.
DeLano WL. The PyMOL Molecular Graphics System, DeLano Scientific LLC, San Carlos, CA. 2002.
Pilot P. Dassault Systèmes BIOVIA, discovery studio modelling environment; 2016.
Danyaya AI, Verma AK, Kumar A, Shuaibu BS, Hamza UA, Yahya NL, et al. Virtual screening, molecular docking and ADME/T analysis of natural product against cell invasion protein SipB from Salmonella enterica serotype typhi: In silico analysis. Acta Scientific Pharmaceutical Science. 2020;4(8);20-30.
Lawal M, Verma AK, Umar IA, Gadanya AM, Umar B, Yahaya NL, et al. Analysis of new potent Anti-Diabetic molecules from phytochemicals of pistia strateotes of Homo sapiens for treatment of diabetes mellitus. An silico Approach. IOSR Journal of Pharmacy and Biological Sciences. 2020;15(4):59-73.